- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips launches high-field MR
The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company.
The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company. The short-bore Intera Enterprise, announced July 24, also comes in a mobile configuration. Philips executives view the entrepreneurial marketplace as an opportunity for growth. They claim a 30% share in MR sales to this U.S. market segment. The four-channel radio-frequency system supports optimized packages for neuro, orthopedic, body, cardiac, and vascular applications.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
